Phio Pharmaceuticals GAAP EPS of -$1.45 beats by $0.31
Source: SeekingAlpha
2026-03-05 17:11:14 ET
More on Phio Pharmaceuticals
- Seeking Alpha’s Quant Rating on Phio Pharmaceuticals
- Historical earnings data for Phio Pharmaceuticals
- Financial information for Phio Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Phio Pharmaceuticals GAAP EPS of -$1.45 beats by $0.31
Phio Pharmaceuticals Corp.
NASDAQ: PHIO
PHIO Trading
-0.21% G/L:
$1.1626 Last:
152,757 Volume:
$1.15 Open:
PHIO Latest News
March 05, 2026 04:05:00 pm
Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update
February 19, 2026 07:00:00 am
Phio Pharmaceuticals Aligns Leadership Team to Support Next Stage Development of PH-762 and Advancement of PH-894
February 10, 2026 07:00:00 am
Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial
January 26, 2026 08:15:00 am
Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference
PHIO Stock Data
$12,716,901
9,242,338
6.1%
8
N/A
Biotechnology & Life Sciences
Healthcare
US
King of Prussia
